Trademarkia Logo

Canada

C$
MIDROPS
REGISTERED

on 9 Aug 2024

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

EYECRO LLC

5301 N. Beverly DriveOklahoma City, OK 73105

US

Serial Number

1959815 filed on 29th Apr 2019

Registration Number

TMA1250392 registered on 9th Aug 2024

Registration expiry Date

9th Aug 2034

Correspondent Address

MBM INTELLECTUAL PROPERTY AGENCY

275 SLATER STREET14TH FLOOROTTAWA

ONTARIO

CA

K1P5H9

MIDROPS

Trademark usage description

eye drops; ophthalmic preparations; pharmaceutical agents used to treat ophthalmic diseases; pharmaceutical anti-allergic preparations and substances; Read More

Classification Information


Class [005]
Eye drops; Ophthalmic preparations; Pharmaceutical agents used to treat ophthalmic diseases; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for ophthalmological use; Antibiotic preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals used to treat ophthalmic diseases; Drug delivery agents in the form of emulsions that facilitate the delivery of pharmaceutical preparations used to treat ophthalmic diseases; Drug delivery agents in the form of micelle that facilitate the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders


Classification kind code

11

Class [040]
Custom manufacture of microemulsions for use in the treatment of ophthalmic diseases


Classification kind code

11

Class [042]
Laboratory research in the field of pharmaceuticals; Laboratory research in the field of biotechnology; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research in the field of pharmaceuticals used to treat ophthalmic diseases; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of chemistry; Research on the subject of pharmaceuticals; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy


Classification kind code

11

Mark Details


Serial Number

1959815

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 1st May 2024
Advertised
Submitted for opposition 26
on 3rd Apr 2024
Approved
Submitted for opposition 27
on 3rd Apr 2024
Approval Notice Sent
Submitted for opposition 22
on 6th Oct 2023
Search Recorded
Submitted for opposition 20
on 6th Oct 2023
Examiner's First Report
Submitted for opposition 48
on 25th Aug 2023
Agent Changed
Submitted for opposition 287
on 9th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 3rd May 2019
Formalized
Submitted for opposition 1
on 30th Apr 2019
Created
Submitted for opposition 30
on 29th Apr 2019
Filed